feed,title,long_url,short_url
TheStreet,Theravance Stock Drops; Ulcerative-Colitis Drug Doesn't Meet Endpoint,https://www.thestreet.com/investing/theravance-drops-ulcerative-colitis-drug-fails-to-meet-endpoint,https://j.mp/3870xJR
